Literature DB >> 31887305

Neuronal ablation of mt-AspRS in mice induces immune pathway activation prior to severe and progressive cortical and behavioral disruption.

Christina L Nemeth1, Sophia N Tomlinson1, Melissa Rosen1, Brett M O'Brien1, Oscar Larraza1, Mahim Jain2, Connor F Murray1, Joel S Marx1, Michael Delannoy3, Amena S Fine4, Dan Wu5, Aleksandra Trifunovic6, Ali Fatemi7.   

Abstract

Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) is a rare, slowly progressive white matter disease caused by mutations in the mitochondrial aspartyl-tRNA synthetase (mt-AspRS, or DARS2). While patients show characteristic MRI T2 signal abnormalities throughout the cerebral white matter, brainstem, and spinal cord, the phenotypic spectrum is broad and a multitude of gene variants have been associated with the disease. Here, Dars2 disruption in CamKIIα-expressing cortical and hippocampal neurons results in slowly progressive increases in behavioral activity at five months, and culminating by nine months as severe brain atrophy, behavioral dysfunction, reduced corpus callosum thickness, and microglial morphology indicative of neuroinflammation. Interestingly, RNAseq based gene expression studies performed prior to the presentation of this severe phenotype reveal the upregulation of several pathways involved in immune activation, cytokine production and signaling, and defense response regulation. RNA transcript analysis demonstrates that activation of immune and cell stress pathways are initiated in advance of a behavioral phenotype and cerebral deficits. An understanding of these pathways and their contribution to significant neuronal loss in CamKII-Dars2 deficient mice may aid in deciphering mechanisms of LBSL pathology.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DARS2; LBSL; Leukodystrophy; Leukoencephalopathy; Mitochondria; tRNA synthetase

Mesh:

Substances:

Year:  2019        PMID: 31887305      PMCID: PMC7448750          DOI: 10.1016/j.expneurol.2019.113164

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  45 in total

Review 1.  Mitochondria at the interface between neurodegeneration and neuroinflammation.

Authors:  Verian Bader; Konstanze F Winklhofer
Journal:  Semin Cell Dev Biol       Date:  2019-06-05       Impact factor: 7.727

2.  Microglial cystatin F expression is a sensitive indicator for ongoing demyelination with concurrent remyelination.

Authors:  Jianmei Ma; Kenji F Tanaka; Takahiro Shimizu; Claude C A Bernard; Akiyoshi Kakita; Hitoshi Takahashi; Steven E Pfeiffer; Kazuhiro Ikenaka
Journal:  J Neurosci Res       Date:  2011-02-22       Impact factor: 4.164

3.  Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation.

Authors:  Gert C Scheper; Thom van der Klok; Rob J van Andel; Carola G M van Berkel; Marie Sissler; Joél Smet; Tatjana I Muravina; Sergey V Serkov; Graziella Uziel; Marianna Bugiani; Raphael Schiffmann; Ingeborg Krägeloh-Mann; Jan A M Smeitink; Catherine Florentz; Rudy Van Coster; Jan C Pronk; Marjo S van der Knaap
Journal:  Nat Genet       Date:  2007-03-25       Impact factor: 38.330

4.  The balance between cathepsin C and cystatin F controls remyelination in the brain of Plp1-overexpressing mouse, a chronic demyelinating disease model.

Authors:  Takahiro Shimizu; Wilaiwan Wisessmith; Jiayi Li; Manabu Abe; Kenji Sakimura; Banthit Chetsawang; Yoshinori Sahara; Koujiro Tohyama; Kenji F Tanaka; Kazuhiro Ikenaka
Journal:  Glia       Date:  2017-03-02       Impact factor: 7.452

5.  Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation is associated with cell-type-dependent splicing of mtAspRS mRNA.

Authors:  Laura van Berge; Stephanie Dooves; Carola G M van Berkel; Emiel Polder; Marjo S van der Knaap; Gert C Scheper
Journal:  Biochem J       Date:  2012-02-01       Impact factor: 3.857

6.  Early-onset LBSL: how severe does it get?

Authors:  M E Steenweg; L van Berge; C G M van Berkel; I F M de Coo; I K Temple; K Brockmann; C I P Mendonça; S Vojta; A Kolk; D Peck; L Carr; G Uziel; A Feigenbaum; S Blaser; G C Scheper; M S van der Knaap
Journal:  Neuropediatrics       Date:  2012-10-12       Impact factor: 1.947

Review 7.  Lysosomal cathepsins and their regulation in aging and neurodegeneration.

Authors:  Veronika Stoka; Vito Turk; Boris Turk
Journal:  Ageing Res Rev       Date:  2016-04-26       Impact factor: 10.895

8.  Haplotype and isoform specific expression estimation using multi-mapping RNA-seq reads.

Authors:  Ernest Turro; Shu-Yi Su; Ângela Gonçalves; Lachlan J M Coin; Sylvia Richardson; Alex Lewin
Journal:  Genome Biol       Date:  2011-02-10       Impact factor: 13.583

9.  Gene Expression Profiling of Multiple Sclerosis Pathology Identifies Early Patterns of Demyelination Surrounding Chronic Active Lesions.

Authors:  Debbie A E Hendrickx; Jackelien van Scheppingen; Marlijn van der Poel; Koen Bossers; Karianne G Schuurman; Corbert G van Eden; Elly M Hol; Jörg Hamann; Inge Huitinga
Journal:  Front Immunol       Date:  2017-12-21       Impact factor: 7.561

10.  Neuroinflammation: Microglia and T Cells Get Ready to Tango.

Authors:  Sjoerd T T Schetters; Diego Gomez-Nicola; Juan J Garcia-Vallejo; Yvette Van Kooyk
Journal:  Front Immunol       Date:  2018-01-25       Impact factor: 7.561

View more
  3 in total

1.  A Hypomorphic Dars1 D367Y Model Recapitulates Key Aspects of the Leukodystrophy HBSL.

Authors:  Dominik Fröhlich; Marisa I Mendes; Andrew J Kueh; Andre Bongers; Marco J Herold; Gajja S Salomons; Gary D Housley; Matthias Klugmann
Journal:  Front Cell Neurosci       Date:  2021-01-20       Impact factor: 5.505

2.  LBSL: Case Series and DARS2 Variant Analysis in Early Severe Forms With Unexpected Presentations.

Authors:  Menno D Stellingwerff; Sonia Figuccia; Emanuele Bellacchio; Karin Alvarez; Claudia Castiglioni; Pinar Topaloglu; Chloe A Stutterd; Corrie E Erasmus; Amarilis Sanchez-Valle; Sebastien Lebon; Sarah Hughes; Thomas Schmitt-Mechelke; Gessica Vasco; Gabriel Chow; Elisa Rahikkala; Cristina Dallabona; Cecilia Okuma; Chiara Aiello; Paola Goffrini; Truus E M Abbink; Enrico S Bertini; Marjo S Van der Knaap
Journal:  Neurol Genet       Date:  2021-02-02

3.  Disruption of Hars2 in Cochlear Hair Cells Causes Progressive Mitochondrial Dysfunction and Hearing Loss in Mice.

Authors:  Pengcheng Xu; Longhao Wang; Hu Peng; Huihui Liu; Hongchao Liu; Qingyue Yuan; Yun Lin; Jun Xu; Xiuhong Pang; Hao Wu; Tao Yang
Journal:  Front Cell Neurosci       Date:  2021-12-15       Impact factor: 5.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.